Literature DB >> 24375459

A review of reward processing and motivational impairment in schizophrenia.

Gregory P Strauss1, James A Waltz, James M Gold.   

Abstract

This article reviews and synthesizes research on reward processing in schizophrenia, which has begun to provide important insights into the cognitive and neural mechanisms associated with motivational impairments. Aberrant cortical-striatal interactions may be involved with multiple reward processing abnormalities, including: (1) dopamine-mediated basal ganglia systems that support reinforcement learning and the ability to predict cues that lead to rewarding outcomes; (2) orbitofrontal cortex-driven deficits in generating, updating, and maintaining value representations; (3) aberrant effort-value computations, which may be mediated by disrupted anterior cingulate cortex and midbrain dopamine functioning; and (4) altered activation of the prefrontal cortex, which is important for generating exploratory behaviors in environments where reward outcomes are uncertain. It will be important for psychosocial interventions targeting negative symptoms to account for abnormalities in each of these reward processes, which may also have important interactions; suggestions for novel behavioral intervention strategies that make use of external cues, reinforcers, and mobile technology are discussed.

Entities:  

Keywords:  anhedonia; avolition; motivation; negative symptoms; psychosis; reward

Mesh:

Year:  2013        PMID: 24375459      PMCID: PMC3934394          DOI: 10.1093/schbul/sbt197

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  101 in total

Review 1.  A new perspective on anhedonia in schizophrenia.

Authors:  Gregory P Strauss; James M Gold
Journal:  Am J Psychiatry       Date:  2012-04       Impact factor: 18.112

Review 2.  The structure of negative symptoms within schizophrenia: implications for assessment.

Authors:  Jack J Blanchard; Alex S Cohen
Journal:  Schizophr Bull       Date:  2005-10-27       Impact factor: 9.306

3.  The NIMH-MATRICS consensus statement on negative symptoms.

Authors:  Brian Kirkpatrick; Wayne S Fenton; William T Carpenter; Stephen R Marder
Journal:  Schizophr Bull       Date:  2006-02-15       Impact factor: 9.306

Review 4.  A neural substrate of prediction and reward.

Authors:  W Schultz; P Dayan; P R Montague
Journal:  Science       Date:  1997-03-14       Impact factor: 47.728

5.  Evidence for an emotion maintenance deficit in schizophrenia.

Authors:  David E Gard; Shanna Cooper; Melissa Fisher; Alexander Genevsky; Joseph A Mikels; Sophia Vinogradov
Journal:  Psychiatry Res       Date:  2011-01-14       Impact factor: 3.222

6.  Neural correlates of probabilistic category learning in patients with schizophrenia.

Authors:  Thomas W Weickert; Terry E Goldberg; Joseph H Callicott; Qiang Chen; Jose A Apud; Sumitra Das; Brad J Zoltick; Michael F Egan; Martijn Meeter; Catherine Myers; Mark A Gluck; Daniel R Weinberger; Venkata S Mattay
Journal:  J Neurosci       Date:  2009-01-28       Impact factor: 6.167

7.  Cognition-emotion interactions are modulated by working memory capacity in individuals with schizophrenia.

Authors:  Gregory P Strauss; Bern G Lee; James A Waltz; Benjamin M Robinson; Jaime K Brown; James M Gold
Journal:  Schizophr Res       Date:  2012-09-08       Impact factor: 4.939

8.  Decision-making impairments in the context of intact reward sensitivity in schizophrenia.

Authors:  Erin A Heerey; Kimberly R Bell-Warren; James M Gold
Journal:  Biol Psychiatry       Date:  2008-04-02       Impact factor: 13.382

9.  Dissociation of hedonic reaction to reward and incentive motivation in an animal model of the negative symptoms of schizophrenia.

Authors:  Ryan D Ward; Eleanor H Simpson; Vanessa L Richards; Gita Deo; Kathleen Taylor; John I Glendinning; Eric R Kandel; Peter D Balsam
Journal:  Neuropsychopharmacology       Date:  2012-03-14       Impact factor: 7.853

10.  The roles of reward, default, and executive control networks in set-shifting impairments in schizophrenia.

Authors:  James A Waltz; Zuzana Kasanova; Thomas J Ross; Betty J Salmeron; Robert P McMahon; James M Gold; Elliot A Stein
Journal:  PLoS One       Date:  2013-02-27       Impact factor: 3.240

View more
  138 in total

Review 1.  The Potential of Cannabidiol Treatment for Cannabis Users With Recent-Onset Psychosis.

Authors:  Britta Hahn
Journal:  Schizophr Bull       Date:  2018-01-13       Impact factor: 9.306

2.  A randomized pilot study of MOtiVation and Enhancement (MOVE) Training for negative symptoms in schizophrenia.

Authors:  Dawn I Velligan; David Roberts; Jim Mintz; Natalie Maples; Xueying Li; Elisa Medellin; Matt Brown
Journal:  Schizophr Res       Date:  2015-05-01       Impact factor: 4.939

3.  Clarifying the overlap between motivation and negative symptom measures in schizophrenia research: A meta-analysis.

Authors:  Lauren Luther; Melanie W Fischer; Ruth L Firmin; Michelle P Salyers
Journal:  Schizophr Res       Date:  2018-12-19       Impact factor: 4.939

Review 4.  Using molecular imaging to understand early schizophrenia-related psychosis neurochemistry: a review of human studies.

Authors:  Christin Schifani; Sina Hafizi; Tania Da Silva; Jeremy Joseph Watts; M Saad Khan; Romina Mizrahi
Journal:  Int Rev Psychiatry       Date:  2017-12-08

5.  Network Analysis Reveals Which Negative Symptom Domains Are Most Central in Schizophrenia vs Bipolar Disorder.

Authors:  Gregory Paul Strauss; Farnaz Zamani Esfahlani; Brian Kirkpatrick; Daniel N Allen; James M Gold; Katherine Frost Visser; Hiroki Sayama
Journal:  Schizophr Bull       Date:  2019-10-24       Impact factor: 9.306

Review 6.  A meta-analytic review of self-reported, clinician-rated, and performance-based motivation measures in schizophrenia: Are we measuring the same "stuff"?

Authors:  Lauren Luther; Ruth L Firmin; Paul H Lysaker; Kyle S Minor; Michelle P Salyers
Journal:  Clin Psychol Rev       Date:  2018-04-07

7.  Pupillometer-based neurofeedback cognitive training to improve processing speed and social functioning in individuals at clinical high risk for psychosis.

Authors:  Jimmy Choi; Cheryl M Corcoran; Joanna M Fiszdon; Michael Stevens; Daniel C Javitt; Melissa Deasy; Lawrence C Haber; Michael J Dewberry; Godfrey D Pearlson
Journal:  Psychiatr Rehabil J       Date:  2016-08-25

8.  Toward an understanding of anticipatory pleasure deficits in schizophrenia: Memory, prospection, and emotion experience.

Authors:  Janelle M Painter; Ann M Kring
Journal:  J Abnorm Psychol       Date:  2016-03-07

9.  Deconstructing Negative Symptoms in Individuals at Clinical High-Risk for Psychosis: Evidence for Volitional and Diminished Emotionality Subgroups That Predict Clinical Presentation and Functional Outcome.

Authors:  Tina Gupta; Henry R Cowan; Gregory P Strauss; Elaine F Walker; Vijay A Mittal
Journal:  Schizophr Bull       Date:  2021-01-23       Impact factor: 9.306

10.  Dopamine Manipulation Affects Response Vigor Independently of Opportunity Cost.

Authors:  Alexandre Zénon; Sophie Devesse; Etienne Olivier
Journal:  J Neurosci       Date:  2016-09-14       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.